CHEMOMAB
Live / Registered — Registered (as of 11 Jul 2023)
What this means for you
Registered since 11 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79335096
- Registration number
- 7102415
- Mark type
- Stylized text
- Filed
- 09 Jan 2022
- Published for opposition
- 25 Apr 2023
- Registered
- 11 Jul 2023
- Attorney of record
- Jacqueline Zion
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal products for the treatment of inflammatory, fibrotic, and autoimmune diseases
- Class 042 — Scientific and technological services: Providing medical research information, namely, biological, chemical, pharmaceutical, and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of fibrotic diseases, autoimmune diseases, and inflammatory diseases; research and development of pharmaceuticals for the treatment of fibrotic diseases, inflammatory diseases, autoimmune diseases
Owner
- Chemomab Therapeutics Ltd., Tel Aviv - Yafo, IL
- Chemomab Therapeutics Ltd., Tel Aviv - Yafo, IL
- Chemomab Therapeutics Ltd., Tel Aviv - Yafo, IL
Prosecution history
- 31 Oct 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Oct 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Oct 2023 — FINAL DISPOSITION PROCESSED
- 11 Oct 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 25 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Apr 2023 — PUBLISHED FOR OPPOSITION
- 24 Apr 2023 — NOTIFICATION PROCESSED BY IB
- 05 Apr 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 05 Apr 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 05 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Feb 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE